Thymic carcinoma: review and update

Abstract

Thymic carcinoma (TC) is a rare thymic epithelial neoplasm with an aggressive clinical course. There are many recognized histologic subtypes as described by the fifth edition of the World Health Organization (WHO) Classification of Thoracic Tumors; however, given the rarity of this tumor group, diagnosis remains a challenge, especially on limited tissue samples. Additionally, rare variants of TC are continuing to be established, particularly in the era of molecular diagnostics. Herein, histologic subtypes are described as the rare subtypes of TC in the context of their immunoprofile, cytogenetic or molecular features, clinical presentation, and ensuing challenges.

Keywords

Thymic carcinoma / NUT carcinoma / thymus / KIT / thymoma

References

[1] Ahmad U,Detterbeck F.Thymic carcinoma outcomes and prognosis: results of an international analysis.J Thorac Cardiovasc Surg2015;149:95-100, 101.e1

[2] Chung DA.Thymic carcinoma--analysis of nineteen clinicopathological studies.Thorac Cardiovasc Surg2000;48:114-9

[3] Eng TY,Jagirdar J,Thomas CR Jr.Thymic carcinoma: state of the art review.Int J Radiat Oncol Biol Phys2004;59:654-64

[4] Kondo K.Therapy for thymic epithelial tumors: a clinical study of 1,320 patients from Japan.Ann Thorac Surg2003;76:878-84; discussion 884

[5] Quagliano PV.Thymic carcinoma: case reports and review.J Thorac Imaging1996;11:66-74

[6] Nasseri F.Clinical and radiologic review of the normal and abnormal thymus: pearls and pitfalls.Radiographics2010;30:413-28

[7] Roden AC,Yi ES.Analysis of MAML2 rearrangement in mucoepidermoid carcinoma of the thymus.Hum Pathol2013;44:2799-805

[8] Zettl A,Wagner K.Recurrent genetic aberrations in thymoma and thymic carcinoma.Am J Pathol2000;157:257-66 PMCID:PMC1850202

[9] Radovich M,Felau I.The integrated genomic landscape of thymic epithelial tumors.Cancer Cell2018;33:244-58.e10 PMCID:PMC5994906

[10] Suster S.Thymic carcinoma. A clinicopathologic study of 60 cases.Cancer1991;67:1025-32

[11] Suster S.Primary thymic epithelial neoplasms showing combined features of thymoma and thymic carcinoma. A clinicopathologic study of 22 cases.Am J Surg Pathol1996;20:1469-80

[12] Detterbeck FC,Huang J.Which way is up?.J Thorac Oncol2011;6:S1730-8

[13] Weissferdt A.Immunohistochemistry in the diagnosis of thymic epithelial neoplasms.Appl Immunohistochem Mol Morphol2014;22:479-87

[14] Nakagawa K,Kunitoh H,Asamura H.Immunohistochemical KIT (CD117) expression in thymic epithelial tumors.Chest2005;128:140-4

[15] Pan CC,Chiang H.KIT (CD117) is frequently overexpressed in thymic carcinomas but is absent in thymomas.J Pathol2004;202:375-81

[16] Marx A,Coindre JM.The 2015 World Health Organization Classification of tumors of the thymus: continuity and changes.J Thorac Oncol2015;10:1383-95 PMCID:PMC4581965

[17] Truong LD,Cagle PT,Schwartz MR.Thymic carcinoma. A clinicopathologic study of 13 cases.Am J Surg Pathol1990;14:151-66

[18] Moran CA.Mucoepidermoid carcinomas of the thymus. A clinicopathologic study of six cases.Am J Surg Pathol1995;19:826-34

[19] Snover DC,Rosai J.Thymic carcinoma. Five distinctive histological variants.Am J Surg Pathol1982;6:451-70

[20] WHO Classification of Tumours Editorial Board. Thoracic tumours. 5th ed. Lyon, France: International Agency for Research on Cancer; 2021

[21] Weissferdt A.Thymic carcinoma, part 1: a clinicopathologic and immunohistochemical study of 65 cases.Am J Clin Pathol2012;138:103-14

[22] Weksler B,Parikh V,Pennathur A.Thymic carcinoma: a multivariate analysis of factors predictive of survival in 290 patients.Ann Thorac Surg2013;95:299-303

[23] Zhao Y,Hu D,Shi J.Surgical treatment and prognosis of thymic squamous cell carcinoma: a retrospective analysis of 105 cases.Ann Thorac Surg2013;96:1019-24

[24] Girard N,Guo T.Comprehensive genomic analysis reveals clinically relevant molecular distinctions between thymic carcinomas and thymomas.Clin Cancer Res2009;15:6790-9 PMCID:PMC2783876

[25] Suster D,Mackinnon AC.Poorly differentiated nonkeratinizing squamous cell carcinoma of the thymus: clinicopathologic and molecular genetic study of 25 cases.Am J Surg Pathol2018;42:1224-36

[26] Thomas de Montpreville V,Le Naoures C.Micronodular thymic carcinoma with lymphoid hyperplasia: relevance of immunohistochemistry with a small panel of antibodies for diagnosis-a RYTHMIC study.Virchows Arch2021;479:741-6

[27] Brown JG,Papotti M.Thymic basaloid carcinoma: a clinicopathologic study of 12 cases, with a general discussion of basaloid carcinoma and its relationship with adenoid cystic carcinoma.Am J Surg Pathol2009;33:1113-24

[28] Chalabreysse L,Adeleine P,Greenland T.Thymic carcinoma: a clinicopathological and immunohistological study of 19 cases.Histopathology2004;44:367-74

[29] Hishida T,Yano M.Japanese Association for Research on the Thymus (JART)Long-term outcome and prognostic factors of surgically treated thymic carcinoma: results of 306 cases from a Japanese Nationwide Database Study.Eur J Cardiothorac Surg2016;49:835-41

[30] Leyvraz S,Chahinian AP.Association of Epstein-Barr virus with thymic carcinoma.N Engl J Med1985;312:1296-9

[31] Xu M,Chen H.Genome sequencing analysis identifies Epstein-Barr virus subtypes associated with high risk of nasopharyngeal carcinoma.Nat Genet2019;51:1131-6 PMCID:PMC6610787

[32] Zhang G,Shen G,Liang C.Association between Epstein-Barr virus and Thymic epithelial tumors: a systematic review.Infect Agent Cancer2019;14:32 PMCID:PMC6836426

[33] Suster D,Mackinnon AC.Expression of PD-L1/PD-1 in lymphoepithelioma-like carcinoma of the thymus.Mod Pathol2018;31:1801-6

[34] Suster S.Spindle cell thymic carcinoma: clinicopathologic and immunohistochemical study of a distinctive variant of primary thymic epithelial neoplasm.Am J Surg Pathol1999;23:691-700

[35] Moritani S,Mukai K.Sarcomatoid carcinoma of the thymus arising in metaplastic thymoma.Histopathology2008;52:409-11

[36] Lu HS,Zhou T.Sarcomatoid thymic carcinoma arising in metaplastic thymoma: a case report.Int J Surg Pathol2011;19:677-80

[37] Hasserjian RP,Rosai J.Carcinoma of the thymus with clear-cell features. Report of eight cases and review of the literature.Am J Surg Pathol1995;19:835-41

[38] Porubsky S,Rückert JC.International Thymic Malignancy Interest Group (ITMIG)EWSR1 translocation in primary hyalinising clear cell carcinoma of the thymus.Histopathology2019;75:431-6

[39] Matsuno Y,Hirohashi S,Rosai J.Papillary carcinoma of the thymus: report of four cases of a new microscopic type of thymic carcinoma. Am.J Surg Pathol1998;22:873-80

[40] Oka S,Honda Y.Thymic papillary adenocarcinoma coexisting with type A thymoma: a case report.Int J Surg Case Rep2019;57:142-44 PMCID:PMC6453800

[41] Kalhor N.Primary thymic adenocarcinomas: a clinicopathological and immunohistochemical study of 16 cases with emphasis on the morphological spectrum of differentiation.Hum Pathol2018;74:73-82

[42] Moser B,Janik S.Adenocarcinoma of the thymus, enteric type: report of 2 cases, and proposal for a novel subtype of thymic carcinoma.Am J Surg Pathol2015;39:541-8

[43] Kwon AY,Chu J.Histologic characteristics of thymic adenocarcinomas: clinicopathologic study of a nine-case series and a review of the literature.Pathol Res Pract2017;213:106-12

[44] Maeda D,Ikeda S.Mucinous adenocarcinoma of the thymus: a distinct variant of thymic carcinoma.Lung Cancer2009;64:22-7

[45] Sakanoue I,Fujimoto D.KRAS mutation-positive mucinous adenocarcinoma originating in the thymus.J Thorac Dis2017;9:E694-7 PMCID:PMC5594120

[46] Lee Y,Lee SH.Characterization of genetic aberrations in a single case of metastatic thymic adenocarcinoma.BMC Cancer2017;17:330 PMCID:PMC5432996

[47] Maghbool M,Nagel I.Primary adenocarcinoma of the thymus: an immunohistochemical and molecular study with review of the literature.BMC Clin Pathol2013;13:17 PMCID:PMC3672093

[48] Takahashi K,Nishimura M.Thymic carcinoma. Outcome of treatment including surgical resection.Jpn J Thorac Cardiovasc Surg2000;48:494-8

[49] Chau NG,Danga K.An anatomical site and genetic-based prognostic model for patients with nuclear protein in testis (NUT) midline carcinoma: analysis of 124 patients.JNCI Cancer Spectr2019;4:pkz094 PMCID:PMC7165803

[50] Haack H,Fry CJ.Diagnosis of NUT midline carcinoma using a NUT-specific monoclonal antibody.Am J Surg Pathol2009;33:984-91 PMCID:PMC2783402

[51] French CA,Faquin WC.Midline carcinoma of children and young adults with NUT rearrangement.J Clin Oncol2004;22:4135-9

[52] Gökmen-Polar Y,Kesler KA,Badve S.NUT midline carcinomas in the thymic region.Mod Pathol2014;27:1649-56

[53] French CA,Kubonishi I,Perez-Atayde AR.BRD4-NUT fusion oncogene: a novel mechanism in aggressive carcinoma.Cancer Res2003;63:304-7

[54] French CA,Walsh EM.NSD3-NUT fusion oncoprotein in NUT midline carcinoma: implications for a novel oncogenic mechanism.Cancer Discov2014;4:928-41 PMCID:PMC4125436

[55] Shiota H,Alekseyenko AA.“Z4” complex member fusions in NUT carcinoma: implications for a novel oncogenic mechanism.Mol Cancer Res2018;16:1826-33 PMCID:PMC6279489

[56] Banki F,Kott MM.Adenoid cystic carcinoma of the thymus gland: a rare tumor.Ann Thorac Surg2010;90:e56-8

[57] Yang MQ,Wang Z,Jiang GY.Primary thymic carcinoma with adenoid cystic carcinoma-like features: a case report and literature review.Medicine (Baltimore)2020;99:e21531 PMCID:PMC7402894

[58] Kanzaki R,Okura E.Thymic carcinoma with adenoid cystic carcinomalike features with distant metastases.Ann Thorac Cardiovasc Surg2012;18:544-7

[59] Toprani TH,Amin MB,Ayala AG.Thymic carcinoma with rhabdoid features.Ann Diagn Pathol2003;7:106-11

[60] Maralakunte M,Debi U,Aggarwal D.Malignant rhabdoid tumor of the mediastinum: a rare variant of thymic carcinoma presenting as superior vena caval syndrome.Arch Clin Med Case Rep2020;4:717-23

[61] Franke A,Fackeldey V.Hepatoid thymic carcinoma: report of a case.Am J Surg Pathol2004;28:250-6

[62] Jeong JS,Jo U,Nam SY.Hepatoid thymic carcinoma: a case report of a rare subtype of thymic carcinoma.J Pathol Transl Med2021;55:230-4 PMCID:PMC8141974

[63] Nonaka D,Rollo JL.Undifferentiated large cell carcinoma of the thymus associated with Castleman disease-like reaction: a distinctive type of thymic neoplasm characterized by an indolent behavior.Am J Surg Pathol2005;29:490-5

[64] Ströbel P,Jakob A.Thymic carcinoma with overexpression of mutated KIT and the response to imatinib.N Engl J Med2004;350:2625-6

[65] National Comprehensive Cancer network. NCCN clinical practice guidelines in oncology (NCCN guidelines) Thymoma and Thymic carcinoma. Available from: https://www.nccn.org/professionals/physician_gls/default.aspx [Last accessed on 24 Mar 2022]